Programmed death ligand 1 expression in human intrahepatic cholangiocarcinoma and its association with prognosis and CD8(+) T-cell immune responses

BACKGROUND: Agents targeting the programmed death ligand 1 (PD-L1)/programmed death receptor 1 immune checkpoint exhibited promising clinical outcomes in a variety of malignant tumors, including intrahepatic cholangiocarcinoma (ICC). However, the relationship between PD-L1 expression and CD8(+) T-ce...

Descripción completa

Detalles Bibliográficos
Autores principales: Zhu, Ying, Wang, Xiang-Yu, Zhang, Yu, Xu, Da, Dong, Jian, Zhang, Ze, Yi, Chen-He, Jia, Hu-Liang, Yang, Xin
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Dove Medical Press 2018
Materias:
Original Research
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6174308/
https://www.ncbi.nlm.nih.gov/pubmed/30323667
http://dx.doi.org/10.2147/CMAR.S172719

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6174308/
https://www.ncbi.nlm.nih.gov/pubmed/30323667
http://dx.doi.org/10.2147/CMAR.S172719

Ejemplares similares